OGFr (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "OGFr" in Serbian language version.

refsWebsite

Global rank Serbian rank

13nih.gov

4^th place

8^th place

9doi.org

2^nd place

4^th place

1elsevier.com

610^th place

653^rd place

doi.org

Zagon IS, Verderame MF, Allen SS, McLaughlin PJ (2000). „Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans”. Brain Res. 856 (1-2): 75—83. PMID 10677613. doi:10.1016/S0006-8993(99)02330-6.
Wu Y, McLaughlin PJ, Zagon IS (1998). „Ontogeny of the opioid growth factor, Met5-enkephalin, preproenkephalin gene expression, and the zeta opioid receptor in the developing and adult aorta of rat”. Dev. Dyn. 211 (4): 327—37. PMID 9566952. doi:10.1002/(SICI)1097-0177(199804)211:4<327::AID-AJA4>3.0.CO;2-J.
Zagon IS, Verderame MF, McLaughlin PJ (2002). „The biology of the opioid growth factor receptor (OGFr)”. Brain Research. Brain Research Reviews. 38 (3): 351—76. PMID 11890982. doi:10.1016/S0165-0173(01)00160-6.
Cheng F, McLaughlin PJ, Verderame MF, Zagon IS (2009). „The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation”. Molecular Biology of the Cell. 20 (1): 319—27. PMC 2613082 . PMID 18923142. doi:10.1091/mbc.E08-07-0681.
Zagon IS, Wu Y, McLaughlin PJ (1999). „Opioid growth factor and organ development in rat and human embryos”. Brain Res. 839 (2): 313—22. PMID 10519055. doi:10.1016/S0006-8993(99)01753-9.
Sassani JW, Zagon IS, McLaughlin PJ (2003). „Opioid growth factor modulation of corneal epithelium: uppers and downers”. Curr. Eye Res. 26 (5): 249—62. PMID 12854052. doi:10.1076/ceyr.26.4.249.15427.
Cheng F, Zagon IS, Verderame MF, McLaughlin PJ (2007). „The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer”. Cancer Research. 67 (21): 10511—8. PMID 17974995. doi:10.1158/0008-5472.CAN-07-1922.
Donahue RN, McLaughlin PJ, Zagon IS (2009). „Cell Proliferation of Human Ovarian Cancer is Regulated by the Opioid Growth Factor - Opioid Growth Factor Receptor Axis”. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 296 (6): R1716—25. PMID 19297547. doi:10.1152/ajpregu.00075.2009.
Zagon IS, Donahue RN, Rogosnitzky M, McLaughlin PJ (2008). „Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function”. Experimental Biology and Medicine (Maywood, N.J.). 233 (8): 968—79. PMID 18480416. doi:10.3181/0802-RM-58.

elsevier.com

linkinghub.elsevier.com

Zagon IS, Verderame MF, McLaughlin PJ (2002). „The biology of the opioid growth factor receptor (OGFr)”. Brain Research. Brain Research Reviews. 38 (3): 351—76. PMID 11890982. doi:10.1016/S0165-0173(01)00160-6.

nih.gov

ncbi.nlm.nih.gov

„Entrez Gene: OGFR opioid growth factor receptor”.
Zagon IS, Verderame MF, Allen SS, McLaughlin PJ (2000). „Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans”. Brain Res. 856 (1-2): 75—83. PMID 10677613. doi:10.1016/S0006-8993(99)02330-6.
Wu Y, McLaughlin PJ, Zagon IS (1998). „Ontogeny of the opioid growth factor, Met5-enkephalin, preproenkephalin gene expression, and the zeta opioid receptor in the developing and adult aorta of rat”. Dev. Dyn. 211 (4): 327—37. PMID 9566952. doi:10.1002/(SICI)1097-0177(199804)211:4<327::AID-AJA4>3.0.CO;2-J.
Zagon IS, Verderame MF, McLaughlin PJ (2002). „The biology of the opioid growth factor receptor (OGFr)”. Brain Research. Brain Research Reviews. 38 (3): 351—76. PMID 11890982. doi:10.1016/S0165-0173(01)00160-6.
Malendowicz LK, Rebuffat P, Tortorella C, Nussdorfer GG, Ziolkowska A, Hochol A (2005). „Effects of met-enkephalin on cell proliferation in different models of adrenocortical-cell growth”. Int. J. Mol. Med. 15 (5): 841—5. PMID 15806307.
Cheng F, McLaughlin PJ, Verderame MF, Zagon IS (2009). „The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation”. Molecular Biology of the Cell. 20 (1): 319—27. PMC 2613082 . PMID 18923142. doi:10.1091/mbc.E08-07-0681.
Zagon IS, Wu Y, McLaughlin PJ (1999). „Opioid growth factor and organ development in rat and human embryos”. Brain Res. 839 (2): 313—22. PMID 10519055. doi:10.1016/S0006-8993(99)01753-9.
Sassani JW, Zagon IS, McLaughlin PJ (2003). „Opioid growth factor modulation of corneal epithelium: uppers and downers”. Curr. Eye Res. 26 (5): 249—62. PMID 12854052. doi:10.1076/ceyr.26.4.249.15427.
Zagon IS, Smith JP, McLaughlin PJ (1999). „Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor”. Int. J. Oncol. 14 (3): 577—84. PMID 10024694.
McLaughlin PJ, Levin RJ, Zagon IS (1999). „Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor”. Int. J. Oncol. 14 (5): 991—8. PMID 10200353.
Cheng F, Zagon IS, Verderame MF, McLaughlin PJ (2007). „The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer”. Cancer Research. 67 (21): 10511—8. PMID 17974995. doi:10.1158/0008-5472.CAN-07-1922.
Donahue RN, McLaughlin PJ, Zagon IS (2009). „Cell Proliferation of Human Ovarian Cancer is Regulated by the Opioid Growth Factor - Opioid Growth Factor Receptor Axis”. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 296 (6): R1716—25. PMID 19297547. doi:10.1152/ajpregu.00075.2009.
Zagon IS, Donahue RN, Rogosnitzky M, McLaughlin PJ (2008). „Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function”. Experimental Biology and Medicine (Maywood, N.J.). 233 (8): 968—79. PMID 18480416. doi:10.3181/0802-RM-58.